Mobile Menu

Liquid Biopsy ONLINE – June 2022

When: June 9, 2022 Time: 3:00 pm

Join us for Liquid Biopsy ONLINE, a 3 part webinar series, where we explore the technologies behind liquid biopsies, their application and how global collaboration can bring them closer to patients.

– – – – –

Webinar 1: PANEL DISCUSSION: Liquid Biopsy: Where are we now?

Thursday 9th June 2022, 3pm BST/ 4pm CET/ 10am EDT

Over a decade since the term liquid biopsy was introduced, we are starting to see the rollout of these non-invasive diagnostic tests into clinics. But we are a long way from saying these are part of routine diagnostic care.

In this webinar, we will bring together global leaders to discuss where we are in our endeavours to bring liquid biopsies to the forefront of care, what we need to overcome to get there and how we can do this in a collaborative way.


  • Sven Borchmann, Principal Investigator, University of Cologne
  • Elin Gray, Associate Professor, Edith Cowan University
  • Pamela Pinzani, Associate Professor, University of Florence

– – – – –

Webinar 2: Liquid biopsies to detect, diagnose and monitor cancers

Thursday 16th June, 3pm BST/ 4pm CET/ 10am EDT

Liquid biopsies can enable the detection and diagnosis of cancer and provide molecular insights into the development of even the rarest of cancers. In this webinar, we will cover the utility of liquid biopsies for cancer detection, diagnosis and monitoring.


  • Clinical considerations for ctDNA analysis of cancer
    – Minetta Liu, Consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic
  • Clinical application of circulating tumor DNA profiling in gastrointestinal stromal tumors
    – Jason Chan, Consultant Medical Oncologist, National Cancer Centre Singapore
  • Liquid biopsies to diagnose and monitor gliomas
  • – Leonora Balaj, Assistant Professor of Neurosurgery, Massachusetts General Hospital, Harvard Medical School

– – – – –

Webinar 3: Searching for a needle in a haystack: isolating rare events in blood

Thursday 23rd June, 3pm BST/ 4pm CET/ 10am EDT

Detecting and isolating circulating biomarkers in blood has been likened to finding a needle in a haystack. With a lack of trust in the technology, improving the data to support the utility of liquid biopsies is a must.

In this webinar, we will dive into case studies finding rare cancer biomarkers in the bloodstream and how this can influence the future of liquid biopsy technologies and their utility.


  • Analytical Technologies for the Analysis of Liquid Biopsy Samples 
    ​- Steven Soper, Professor, University of Kansas
  • Custom enrichment for RNA sequencing of liquid biopsies 
    – Jo Vandesompele, Ph.D, Director Scientific Initiative, CellCarta
  • New look at blood-lymph liquid biopsy of cancer stem cells in vivo and in vitro
    – Ekaterina Galanzha, Associate Professor, University of Arkansas for Medical Sciences

– – – – –

Register for Liquid Biopsy ONLINE here:


Sven Borchmann Sven Borchmann, Principal Investigator, University of Cologne

Elin Gray Elin Gray, Associate Professor, Edith Cowan University

Pamela Pinzani Pamela Pinzani, Associate Professor, University of Florence

Minetta Liu Minetta Liu, Consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic

Leonora Balaj Leonora Balaj, Assistant Professor of Neurosurgery, Massachusetts General Hospital, Harvard Medical School

Jason Chan Jason Chan, Consultant Medical Oncologist, National Cancer Centre Singapore

Steven Soper Steven Soper, Professor, University of Kansas

Ekaterina Galanzha Ekaterina Galanzha, Associate Professor, University of Arkansas for Medical Sciences

Jo Vandesompele Jo Vandesompele, Director Scientific Initiative, CellCarta

More on these topics

Biomarkers / Cancer / Liquid Biopsy / Oncology / Webinar

Article Search